Maypharm's Hyalmass filler obtains CE mark

Maypharm’s Hyalmass filler with hybrid technology is ready to go beyond the Asian market (Vietnam, Philippines, Thailand, China), after it passed the clinical preliminaries to guarantee its performance. Along with it, the products Metoo fill, Sedy fill, Metox, Mennus, Hairna and Eyebella, have received CE certification.

Hyalmass, a cosmetic treatment is developed by adding a local anaesthetic lidocaine to reduce pain during the procedure. It also contains a soft tissue material hyaluronic acid and aimed at temporary improvement of wrinkles. Hyalmass is made of a homogenised hyaluronic acid – a product of Maypharm – that creates a high bio-compatibility rate. It aims to restore volume and smooth out facial wrinkles. This procedure is performed using hyaluronic acid, a naturally occurring substance in the body that provides hydration and fullness to the skin.

A unique push rod in the Hyalmass enables the user to insert it with minimal effort during the procedure. The handle is designed to fit the hands of any size for better grip and to prevent slipping.

According to Maypharm, the Hyalmass filler will show immediate and noticeable results, and patients can expect an improvement in the appearance of wrinkles, fine lines, and sagging skin, as well as an increase in overall facial volume. The results can last for up to 12 months and the treatment is safe and effective for most people.

In conclusion, Hyalmass filler is a popular cosmetic treatment that offers a simple and effective solution for restoring volume and smoothing out wrinkles in the face.

Maypharm is looking forward to becoming well-known manufacturer of dermal fillers for their safety and efficiency, and being on highest demand on every market, Asia, Middle East and Africa or South and North America.